These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
521 related articles for article (PubMed ID: 32655129)
1. HDAC3-dependent transcriptional repression of FOXA2 regulates FTO/m6A/MYC signaling to contribute to the development of gastric cancer. Yang Z; Jiang X; Zhang Z; Zhao Z; Xing W; Liu Y; Jiang X; Zhao H Cancer Gene Ther; 2021 Feb; 28(1-2):141-155. PubMed ID: 32655129 [TBL] [Abstract][Full Text] [Related]
2. microRNA-96 promotes occurrence and progression of colorectal cancer via regulation of the AMPKα2-FTO-m6A/MYC axis. Yue C; Chen J; Li Z; Li L; Chen J; Guo Y J Exp Clin Cancer Res; 2020 Nov; 39(1):240. PubMed ID: 33183350 [TBL] [Abstract][Full Text] [Related]
3. FTO up-regulation induced by MYC suppresses tumour progression in Epstein-Barr virus-associated gastric cancer. Xu YY; Li T; Shen A; Bao XQ; Lin JF; Guo LZ; Meng Q; Ruan DY; Zhang QH; Zuo ZX; Zeng ZL Clin Transl Med; 2023 Dec; 13(12):e1505. PubMed ID: 38082402 [TBL] [Abstract][Full Text] [Related]
4. HOXB13 promotes gastric cancer cell migration and invasion via IGF-1R upregulation and subsequent activation of PI3K/AKT/mTOR signaling pathway. Guo C; Chu H; Gong Z; Zhang B; Li C; Chen J; Huang L Life Sci; 2021 Aug; 278():119522. PubMed ID: 33894267 [TBL] [Abstract][Full Text] [Related]
5. RNA N6-methyladenosine demethylase FTO promotes breast tumor progression through inhibiting BNIP3. Niu Y; Lin Z; Wan A; Chen H; Liang H; Sun L; Wang Y; Li X; Xiong XF; Wei B; Wu X; Wan G Mol Cancer; 2019 Mar; 18(1):46. PubMed ID: 30922314 [TBL] [Abstract][Full Text] [Related]
6. FTO Prevents Thyroid Cancer Progression by SLC7A11 m6A Methylation in a Ferroptosis-Dependent Manner. Ji FH; Fu XH; Li GQ; He Q; Qiu XG Front Endocrinol (Lausanne); 2022; 13():857765. PubMed ID: 35721711 [TBL] [Abstract][Full Text] [Related]
7. Level of N6-Methyladenosine in Peripheral Blood RNA: A Novel Predictive Biomarker for Gastric Cancer. Ge L; Zhang N; Chen Z; Song J; Wu Y; Li Z; Chen F; Wu J; Li D; Li J; Wang C; Wang H; Wang J Clin Chem; 2020 Feb; 66(2):342-351. PubMed ID: 32040577 [TBL] [Abstract][Full Text] [Related]
8. HDAC3-Mediated Repression of LncRNA-LET Regulates Gastric Cancer Cell Growth Proliferation, Invasion, Migration, and Apoptosis via MiR-548k. Zhang J; Liu X; Chen J; Xia S J Environ Pathol Toxicol Oncol; 2021; 40(4):21-32. PubMed ID: 34936297 [TBL] [Abstract][Full Text] [Related]
9. FTO promotes gastric cancer progression by modulating MAP4K4 expression via demethylation in an m6A-dependent manner. Yin Z; Guo X; Liang X; Wang Z Med Oncol; 2024 Apr; 41(5):120. PubMed ID: 38643333 [TBL] [Abstract][Full Text] [Related]
10. HBXIP promotes gastric cancer Yang Z; Jiang X; Li D; Jiang X Aging (Albany NY); 2020 Oct; 12(24):24967-24982. PubMed ID: 33048840 [TBL] [Abstract][Full Text] [Related]
11. Fat mass and obesity-associated protein (FTO) mediated m Wu X; Fang Y; Gu Y; Shen H; Xu Y; Xu T; Shi R; Xu D; Zhang J; Leng K; Shu Y; Ma P Mol Biomed; 2024 Apr; 5(1):11. PubMed ID: 38556586 [TBL] [Abstract][Full Text] [Related]
12. FTO-mediated regulation of m6A methylation is closely related to apoptosis induced by repeated UV irradiation. Lin Y; Sun Y; Hou W; Chen X; Zhou F; Xu Q; Zheng Y J Dermatol Sci; 2024 Jun; 114(3):124-132. PubMed ID: 38749796 [TBL] [Abstract][Full Text] [Related]
13. Novel evidence for m Shimura T; Kandimalla R; Okugawa Y; Ohi M; Toiyama Y; He C; Goel A Br J Cancer; 2022 Feb; 126(2):228-237. PubMed ID: 34675398 [TBL] [Abstract][Full Text] [Related]
14. Kinase GSK3β functions as a suppressor in colorectal carcinoma through the FTO-mediated MZF1/c-Myc axis. Zhang Z; Gao Q; Wang S J Cell Mol Med; 2021 Mar; 25(5):2655-2665. PubMed ID: 33533172 [TBL] [Abstract][Full Text] [Related]
15. Expression of Demethylase Genes, FTO and ALKBH1, Is Associated with Prognosis of Gastric Cancer. Li Y; Zheng D; Wang F; Xu Y; Yu H; Zhang H Dig Dis Sci; 2019 Jun; 64(6):1503-1513. PubMed ID: 30637548 [TBL] [Abstract][Full Text] [Related]
16. RNA N6-methyladenosine demethylase FTO targets MOXD1 promoting the malignant phenotype of gastric cancer. Lai Y; Dong H; Xu P; Wang J; Feng W; Zhao Z; Sha L BMC Gastroenterol; 2024 Jan; 24(1):29. PubMed ID: 38200441 [TBL] [Abstract][Full Text] [Related]
17. METTL3-mediated N6-methyladenosine modification is critical for epithelial-mesenchymal transition and metastasis of gastric cancer. Yue B; Song C; Yang L; Cui R; Cheng X; Zhang Z; Zhao G Mol Cancer; 2019 Oct; 18(1):142. PubMed ID: 31607270 [TBL] [Abstract][Full Text] [Related]
18. RNA demethylase FTO participates in malignant progression of gastric cancer by regulating SP1-AURKB-ATM pathway. Zeng X; Lu Y; Zeng T; Liu W; Huang W; Yu T; Tang X; Huang P; Li B; Wei H Commun Biol; 2024 Jul; 7(1):800. PubMed ID: 38956367 [TBL] [Abstract][Full Text] [Related]
19. The tumor-suppressive effects of alpha-ketoglutarate-dependent dioxygenase FTO via N6-methyladenosine RNA methylation on bladder cancer patients. Yi W; Yu Y; Li Y; Yang J; Gao S; Xu L Bioengineered; 2021 Dec; 12(1):5323-5333. PubMed ID: 34499008 [TBL] [Abstract][Full Text] [Related]
20. M6A RNA Methylation-Based Epitranscriptomic Modifications in Plasticity-Related Genes via miR-124-C/EBPα-FTO-Transcriptional Axis in the Hippocampus of Learned Helplessness Rats. Roy B; Ochi S; Dwivedi Y Int J Neuropsychopharmacol; 2022 Dec; 25(12):1037-1049. PubMed ID: 36161325 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]